Mc Adam, LLC Charles River Laboratories International, Inc. Transaction History

Mc Adam, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$203.52 - $273.43 $14,653 - $19,686	-72 Reduced 7.81%	850 $230,000
Q4 2023 Feb 05, 2024	SELL	$164.52 - $238.84 $22,374 - $32,482	-136 Reduced 12.85%	922 $217,000
Q3 2023 Oct 31, 2023	SELL	$194.44 - $217.61 $583 - $652	-3 Reduced 0.28%	1,058 $207,000
Q2 2023 Aug 02, 2023	BUY	$183.71 - $210.25 $194,916 - $223,075	1,061 New	1,061 $223,000
Q2 2022 Jul 15, 2022	SELL	$204.13 - $302.4 $169,836 - $251,596	-832 Closed	0 $0
Q1 2022 Apr 07, 2022	BUY	$255.51 - $362.11 $212,584 - $301,275	832 New	832 $236,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.